Other Species / Isoforms
  NCKAP5L (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
P12
MDQPAGGPGNPRPGE
0 1
NCKAP5L (human) MDQPAGGPGNPRPGE P12
NCKAP5L iso2 (human) MDQPAGGPGNPRPGE P12
NCKAP5L (mouse) MDQPAGGtGKLRASA T8-p
NCKAP5L (rat) MDQPAGGTGNLRPAS T8
S132-p
PPSEPPAsPSLSSTE
0 1
NCKAP5L (human) PPSEPPAsPSLSSTE S132-p
NCKAP5L iso2 (human) PPSEPPASPSLSSTE S132
NCKAP5L (mouse) PPSERPTSPAPNVSE S128
NCKAP5L (rat) PPSERPASPSPNAAE S128
A172
GGPGPPAAPPPALDA
0 2
NCKAP5L (human) GGPGPPAAPPPALDA A172
NCKAP5L iso2 (human) GGPGPPAAPPPALDA A172
NCKAP5L (mouse) GGPGPPAtPPPALDA T168-p
NCKAP5L (rat) GGPGPPATPPPALDA T168
S181-p
PPALDALsPFLRKkA
0 7
NCKAP5L (human) PPALDALsPFLRKkA S181-p
NCKAP5L iso2 (human) PPALDALSPFLRKKA S181
NCKAP5L (mouse) PPALDALsPFLRKKA S177-p
NCKAP5L (rat) PPALDALSPFLRKKA S177
K187-ub
LsPFLRKkAQILEVL
0 1
NCKAP5L (human) LsPFLRKkAQILEVL K187-ub
NCKAP5L iso2 (human) LSPFLRKKAQILEVL K187
NCKAP5L (mouse) LsPFLRKKAQILEVL K183
NCKAP5L (rat) LSPFLRKKAQILEVL K183
K431-ub
PHSSSQVksKLQIGP
0 1
NCKAP5L (human) PHSSSQVksKLQIGP K431-ub
NCKAP5L iso2 (human) PHSSSQVKSKLQIGP K431
NCKAP5L (mouse) PHSSSQVKSKLQIGP K427
NCKAP5L (rat) SHSSSQVKSKLQIGL K429
S432-p
HSSSQVksKLQIGPP
0 1
NCKAP5L (human) HSSSQVksKLQIGPP S432-p
NCKAP5L iso2 (human) HSSSQVKSKLQIGPP S432
NCKAP5L (mouse) HSSSQVKSKLQIGPP S428
NCKAP5L (rat) HSSSQVKSKLQIGLP S430
S440-p
KLQIGPPsPGEAQGP
Upstream
1 15
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • ischemia
  • nocodazole
  • purvalanol
view more >
NCKAP5L (human) KLQIGPPsPGEAQGP S440-p
NCKAP5L iso2 (human) KLQIGPPSPGEAQGP S440
NCKAP5L (mouse) KLQIGPPsPGDAQGP S436-p
NCKAP5L (rat) KLQIGLPSPGDAQGP S438
S451-p
AQGPLLPsPARGLKF
Upstream
1 12
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • purvalanol
NCKAP5L (human) AQGPLLPsPARGLKF S451-p
NCKAP5L iso2 (human) AQGPLLPSPARGLKF S451
NCKAP5L (mouse) AQGPLLPSPARGLKF S447
NCKAP5L (rat) AQGPLLPSPARGLKF S449
S468-p
LPPTSEKsPsPGGPQ
0 3
NCKAP5L (human) LPPTSEKsPsPGGPQ S468-p
NCKAP5L iso2 (human) LPPTSEKSPSPGGPQ S468
NCKAP5L (mouse) LPPASEKVPSPGGPQ V464
NCKAP5L (rat) LPPASEKVPSPGGPQ V466
S470-p
PTSEKsPsPGGPQLs
Upstream
1 3
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • purvalanol
NCKAP5L (human) PTSEKsPsPGGPQLs S470-p
NCKAP5L iso2 (human) PTSEKSPSPGGPQLS S470
NCKAP5L (mouse) PASEKVPSPGGPQLs S466
NCKAP5L (rat) PASEKVPSPGGPQLs S468
S477-p
sPGGPQLsPQLPRNS
Upstream
1 26
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • BI2536
  • ischemia
  • LRRK2-IN-1
  • nocodazole
  • purvalanol
view more >
NCKAP5L (human) sPGGPQLsPQLPRNS S477-p
NCKAP5L iso2 (human) SPGGPQLSPQLPRNS S477
NCKAP5L (mouse) SPGGPQLsPQLPRSS S473-p
NCKAP5L (rat) SPGGPQLsPQLPRSS S475-p
S491-p
SRIPCRNsGsDGsPs
0 3
NCKAP5L (human) SRIPCRNsGsDGsPs S491-p
NCKAP5L iso2 (human) SRIPCRNSGSDGSPS S491
NCKAP5L (mouse) SRIPCRNsGsDGSPs S487-p
NCKAP5L (rat) SRIPCRNSGsDGSPs S489
S493-p
IPCRNsGsDGsPsPL
Upstream
0 20
Treatment
  • nocodazole
NCKAP5L (human) IPCRNsGsDGsPsPL S493-p
NCKAP5L iso2 (human) IPCRNSGSDGSPSPL S493
NCKAP5L (mouse) IPCRNsGsDGSPsPL S489-p
NCKAP5L (rat) IPCRNSGsDGSPsPL S491-p
S496-p
RNsGsDGsPsPLLAR
Upstream
0 7
Treatment
  • nocodazole
NCKAP5L (human) RNsGsDGsPsPLLAR S496-p
NCKAP5L iso2 (human) RNSGSDGSPSPLLAR S496
NCKAP5L (mouse) RNsGsDGSPsPLLAR S492
NCKAP5L (rat) RNSGsDGSPsPLLAR S494
S498-p
sGsDGsPsPLLARRG
Upstream
0 27
Treatment
  • ischemia
  • nocodazole
NCKAP5L (human) sGsDGsPsPLLARRG S498-p
NCKAP5L iso2 (human) SGSDGSPSPLLARRG S498
NCKAP5L (mouse) sGsDGSPsPLLARRG S494-p
NCKAP5L (rat) SGsDGSPsPLLARRG S496-p
T566-p
ILDLSRStFRGPsPE
0 1
NCKAP5L (human) ILDLSRStFRGPsPE T566-p
NCKAP5L iso2 (human) ILDLSRSTFRGPSPE T566
NCKAP5L (mouse) ILDLSRSTFRGSPPE T562
NCKAP5L (rat) ILDLSRGTFRGSSTE T564
S571-p
RStFRGPsPEPPPsP
Upstream
1 6
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • purvalanol
NCKAP5L (human) RStFRGPsPEPPPsP S571-p
NCKAP5L iso2 (human) RSTFRGPSPEPPPSP S571
NCKAP5L (mouse) RSTFRGSPPEPPPSP P567
NCKAP5L (rat) RGTFRGSSTEPPPSP S569
S577-p
PsPEPPPsPLQVPTY
Upstream
1 8
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • nocodazole
  • purvalanol
NCKAP5L (human) PsPEPPPsPLQVPTY S577-p
NCKAP5L iso2 (human) PSPEPPPSPLQVPTY S577
NCKAP5L (mouse) SPPEPPPSPLQVPTY S573
NCKAP5L (rat) SSTEPPPSPLQVPTY S575
S630-p
LDKAGSEsPHPGRRT
0 6
NCKAP5L (human) LDKAGSEsPHPGRRT S630-p
NCKAP5L iso2 (human) LDKAGSESPHPGRRT S630
NCKAP5L (mouse) MDRAGSEsPHASRRT S625-p
NCKAP5L (rat) VDRAGSESPHLSRRT S627
K643-ub
RTPGNSSkkPSQGsG
0 1
NCKAP5L (human) RTPGNSSkkPSQGsG K643-ub
NCKAP5L iso2 (human) RTPGNSSKKPSQGSG K643
NCKAP5L (mouse) RTPGGSSKKPGQGsG K638
NCKAP5L (rat) RTPCGSSKKPGQGSG K640
K644-ub
TPGNSSkkPSQGsGR
0 1
NCKAP5L (human) TPGNSSkkPSQGsGR K644-ub
NCKAP5L iso2 (human) TPGNSSKKPSQGSGR K644
NCKAP5L (mouse) TPGGSSKKPGQGsGR K639
NCKAP5L (rat) TPCGSSKKPGQGSGR K641
S649-p
SkkPSQGsGRRPGDP
0 2
NCKAP5L (human) SkkPSQGsGRRPGDP S649-p
NCKAP5L iso2 (human) SKKPSQGSGRRPGDP S649
NCKAP5L (mouse) SKKPGQGsGRRPGDP S644-p
NCKAP5L (rat) SKKPGQGSGRRPGDP S646
S658-p
RRPGDPGstPLRDRL
0 1
NCKAP5L (human) RRPGDPGstPLRDRL S658-p
NCKAP5L iso2 (human) RRPGDPGSTPLRDRL S658
NCKAP5L (mouse) RRPGDPSHtPLRDRL H653
NCKAP5L (rat) RRPGDPSHTPLRDRL H655
T659-p
RPGDPGstPLRDRLA
0 5
NCKAP5L (human) RPGDPGstPLRDRLA T659-p
NCKAP5L iso2 (human) RPGDPGSTPLRDRLA T659
NCKAP5L (mouse) RPGDPSHtPLRDRLA T654-p
NCKAP5L (rat) RPGDPSHTPLRDRLA T656
K670
DRLAALGKLKTGPEG
0 1
NCKAP5L (human) DRLAALGKLKTGPEG K670
NCKAP5L iso2 (human) DRLAALGKLKTGPEG K670
NCKAP5L (mouse) DRLAALGKLKTGPEG K665
NCKAP5L (rat) DRLAALGkLKTGPEG K667-ac
K670-ub
DRLAALGkLKTGPEG
0 1
NCKAP5L (human) DRLAALGkLKTGPEG K670-ub
NCKAP5L iso2 (human) DRLAALGKLKTGPEG K670
NCKAP5L (mouse) DRLAALGKLKTGPEG K665
NCKAP5L (rat) DRLAALGKLKTGPEG K667
T733-p
RGAVALGtNsLKQQE
0 4
NCKAP5L (human) RGAVALGtNsLKQQE T733-p
NCKAP5L iso2 (human) RGAVALGTNSLKQQE T733
NCKAP5L (mouse) RGAVALGTSSLKQQE T727
NCKAP5L (rat) RGAVALGTSSLKQQE T729
S735-p
AVALGtNsLKQQEPG
0 7
NCKAP5L (human) AVALGtNsLKQQEPG S735-p
NCKAP5L iso2 (human) AVALGTNSLKQQEPG S735
NCKAP5L (mouse) AVALGTSSLKQQEPG S729
NCKAP5L (rat) AVALGTSSLKQQEPG S731
Y752-p
GDPGARVySSHsMGA
0 10
NCKAP5L (human) GDPGARVySSHsMGA Y752-p
NCKAP5L iso2 (human) GDPGARVYSSHSMGA Y752
NCKAP5L (mouse) TDPGARVYSSHsMGA Y745
NCKAP5L (rat) TDLGARVYSSHSMGA Y747
S756-p
ARVySSHsMGARVDL
0 4
NCKAP5L (human) ARVySSHsMGARVDL S756-p
NCKAP5L iso2 (human) ARVYSSHSMGARVDL S756
NCKAP5L (mouse) ARVYSSHsMGARVDL S749-p
NCKAP5L (rat) ARVYSSHSMGARVDL S751
S767-p
RVDLEPVsPRSCLTk
Upstream
1 24
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • ischemia
  • nocodazole
  • purvalanol
  • selumetinib
  • vemurafenib
view more >
NCKAP5L (human) RVDLEPVsPRSCLTk S767-p
NCKAP5L iso2 (human) RVDLEPVSPRSCLTK S767
NCKAP5L (mouse) RVDLEPIsPRSCLTK S760-p
NCKAP5L (rat) RVDLEPIsPRSCLTK S762-p
K774-ub
sPRSCLTkVELAkSR
0 1
NCKAP5L (human) sPRSCLTkVELAkSR K774-ub
NCKAP5L iso2 (human) SPRSCLTKVELAKSR K774
NCKAP5L (mouse) sPRSCLTKVELAKSR K767
NCKAP5L (rat) sPRSCLTKVELAKSR K769
K779-ub
LTkVELAkSRLAGAL
0 1
NCKAP5L (human) LTkVELAkSRLAGAL K779-ub
NCKAP5L iso2 (human) LTKVELAKSRLAGAL K779
NCKAP5L (mouse) LTKVELAKSRLAGAL K772
NCKAP5L (rat) LTKVELAKSRLAGAL K774
T799-p
RTPAKVPtSAPsLGK
0 1
NCKAP5L (human) RTPAKVPtSAPsLGK T799-p
NCKAP5L iso2 (human) RTPAKVPTSAPSLGK T799
NCKAP5L (mouse) RTPAKVPTSAPSLGK T792
NCKAP5L (rat) RTPAKVPTSAPSLGK T794
S803-p
KVPtSAPsLGKPNKs
0 2
NCKAP5L (human) KVPtSAPsLGKPNKs S803-p
NCKAP5L iso2 (human) KVPTSAPSLGKPNKS S803
NCKAP5L (mouse) KVPTSAPSLGKPKsP S796
NCKAP5L (rat) KVPTSAPSLGKPKSP S798
S810-p
sLGKPNKsPHSSPtK
Upstream
0 7
Treatment
  • BI2536
  • LRRK2-IN-1
NCKAP5L (human) sLGKPNKsPHSSPtK S810-p
NCKAP5L iso2 (human) SLGKPNKSPHSSPTK S810
NCKAP5L (mouse) PSLGKPKsPHSSPTK S802-p
NCKAP5L (rat) PSLGKPKSPHSSPTK S804
T816-p
KsPHSSPtKLPSKSP
Upstream
0 1
Treatment
  • BI2536
NCKAP5L (human) KsPHSSPtKLPSKSP T816-p
NCKAP5L iso2 (human) KSPHSSPTKLPSKSP T816
NCKAP5L (mouse) KsPHSSPTKLPSKSP T808
NCKAP5L (rat) KSPHSSPTKLPSKSP T810
S839-p
APLVTKEsPKPDKGK
0 5
NCKAP5L (human) APLVTKEsPKPDKGK S839-p
NCKAP5L iso2 (human) APLVTKESPKPDKGK S839
NCKAP5L (mouse) VPLGTKEPPKPDKVK P831
NCKAP5L (rat) APLGTKEPPKPDKVK P833
K889-ub
AIEEKVMkGIEENVL
0 1
NCKAP5L (human) AIEEKVMkGIEENVL K889-ub
NCKAP5L iso2 (human) AIEEKVMKGIEENVL K889
NCKAP5L (mouse) AIEEKVMKGIEENVL K881
NCKAP5L (rat) AIEEKVMKGIEENVL K883
K924-m1
IASWFGLkKSKLPAL
0 1
NCKAP5L (human) IASWFGLkKSKLPAL K924-m1
NCKAP5L iso2 (human) IASWFGLKKSKLPAL K924
NCKAP5L (mouse) IASWFGLKKsKLPAL K916
NCKAP5L (rat) IASWFGLKKSKLPAL K918
S926
SWFGLkKSKLPALNR
0 1
NCKAP5L (human) SWFGLkKSKLPALNR S926
NCKAP5L iso2 (human) SWFGLKKSKLPALNR S926
NCKAP5L (mouse) SWFGLKKsKLPALNR S918-p
NCKAP5L (rat) SWFGLKKSKLPALNR S920
S948-p
KEGAGGGsPLRREVK
0 2
NCKAP5L (human) KEGAGGGsPLRREVK S948-p
NCKAP5L iso2 (human) KEGAGGGSPLRREVK S948
NCKAP5L (mouse) KDGAGGGSPLRKEVK S940
NCKAP5L (rat) KEGAGGGSPLRKEVK S942
K960-ub
EVKMEARkLEAEsLN
0 1
NCKAP5L (human) EVKMEARkLEAEsLN K960-ub
NCKAP5L iso2 (human) EVKMEARKLEAESLN K960
NCKAP5L (mouse) EVKTEARKLEAESLN K952
NCKAP5L (rat) EVKTEAWKLEAESLN K954
S965-p
ARkLEAEsLNISkLM
Upstream
0 2
Treatment
  • Y27632
NCKAP5L (human) ARkLEAEsLNISkLM S965-p
NCKAP5L iso2 (human) ARKLEAESLNISKLM S965
NCKAP5L (mouse) ARKLEAESLNISKLM S957
NCKAP5L (rat) AWKLEAESLNISKLM S959
K970-ub
AEsLNISkLMAkAED
0 1
NCKAP5L (human) AEsLNISkLMAkAED K970-ub
NCKAP5L iso2 (human) AESLNISKLMAKAED K970
NCKAP5L (mouse) AESLNISKLMAKAED K962
NCKAP5L (rat) AESLNISKLMAKAED K964
K974-ub
NISkLMAkAEDLRRA
0 1
NCKAP5L (human) NISkLMAkAEDLRRA K974-ub
NCKAP5L iso2 (human) NISKLMAKAEDLRRA K974
NCKAP5L (mouse) NISKLMAKAEDLRRA K966
NCKAP5L (rat) NISKLMAKAEDLRRA K968
K986-ub
RRALEEEkAyLSSRA
0 1
NCKAP5L (human) RRALEEEkAyLSSRA K986-ub
NCKAP5L iso2 (human) RRALEEEKAYLSSRA K986
NCKAP5L (mouse) RRALEEEKAYLSRAR K978
NCKAP5L (rat) RRALEEEKAYLSRAR K980
Y988-p
ALEEEkAyLSSRARP
0 2
NCKAP5L (human) ALEEEkAyLSSRARP Y988-p
NCKAP5L iso2 (human) ALEEEKAYLSSRARP Y988
NCKAP5L (mouse) ALEEEKAYLSRARPR Y980
NCKAP5L (rat) ALEEEKAYLSRARPR Y982
K1041-ub
DGKELPSkSWREPkP
0 1
NCKAP5L (human) DGKELPSkSWREPkP K1041-ub
NCKAP5L iso2 (human) DGKELPSKSWREPKP K1041
NCKAP5L (mouse) DGKELPPKSWREPKP K1032
NCKAP5L (rat) DGKDLPPESWREPKP E1034
K1047-ub
SkSWREPkPEyGDFQ
0 1
NCKAP5L (human) SkSWREPkPEyGDFQ K1047-ub
NCKAP5L iso2 (human) SKSWREPKPEYGDFQ K1047
NCKAP5L (mouse) PKSWREPKPEYGDFQ K1038
NCKAP5L (rat) PESWREPKPEYGDFQ K1040
Y1050-p
WREPkPEyGDFQPVS
0 5
NCKAP5L (human) WREPkPEyGDFQPVS Y1050-p
NCKAP5L iso2 (human) WREPKPEYGDFQPVS Y1050
NCKAP5L (mouse) WREPKPEYGDFQPVS Y1041
NCKAP5L (rat) WREPKPEYGDFQPVS Y1043
S1062-p
PVSSDPKsPWPACGP
0 4
NCKAP5L (human) PVSSDPKsPWPACGP S1062-p
NCKAP5L iso2 (human) PVSSDPKSPWPACGP S1062
NCKAP5L (mouse) PVSTDPKSPWPACGP S1053
NCKAP5L (rat) PVSSDPKSPWPACGP S1055
T1175-p
KVPRRAHtLEREVPG
0 14
NCKAP5L (human) KVPRRAHtLEREVPG T1175-p
NCKAP5L iso2 (human) KVPRRAHTLEREVPG T1175
NCKAP5L (mouse) KVPRRAHTLEREVPG T1165
NCKAP5L (rat) KVPRRAHTLEREVPG T1167
S1194-p
LVSGRHPsMPAFPAL
0 5
NCKAP5L (human) LVSGRHPsMPAFPAL S1194-p
NCKAP5L iso2 (human) LVSGRHPSMPAFPAL S1194
NCKAP5L (mouse) LVSGRHPSMPAFPGL S1184
NCKAP5L (rat) LVSGRHPSMPAFPAL S1186
T1225-p
PCEDPGPtPPVQLAK
0 17
NCKAP5L (human) PCEDPGPtPPVQLAK T1225-p
NCKAP5L iso2 (human) PCEDPGPTPPVQLAK T1225
NCKAP5L (mouse) PCEDPGPPPPVQLAK P1215
NCKAP5L (rat) PCEDPGPPPPVQLAK P1217
T1235-p
VQLAKNWtFPNTRAA
0 15
NCKAP5L (human) VQLAKNWtFPNTRAA T1235-p
NCKAP5L iso2 (human) VQLAKNWTFPNTRAA T1235
NCKAP5L (mouse) VQLAKNWtFPNTRTA T1225-p
NCKAP5L (rat) VQLAKNWTFPNTRTS T1227
R1254
DPLMCPPRQLEGLPR
0 1
NCKAP5L (human) DPLMCPPRQLEGLPR R1254
NCKAP5L iso2 (human) DPLMCPPRQLEGLPR R1254
NCKAP5L (mouse) DPFLCPPrQLEGLPR R1244-m1
NCKAP5L (rat) DPFLCPPRQLEGLPR R1246
S1280-p
SQEPSRPsPTPQGPP
0 3
NCKAP5L (human) SQEPSRPsPTPQGPP S1280-p
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) SVDPSRTSTPQGPAF S1270
NCKAP5L (rat) SLDPSRTSMPQGPAF S1272
S1291-p
QGPPFGGsRTPstSD
0 3
NCKAP5L (human) QGPPFGGsRTPstSD S1291-p
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) QGPAFGGsRTPstSD S1280-p
NCKAP5L (rat) QGPAFGGSRTPSTSD S1282
S1295-p
FGGsRTPstSDMAEE
Upstream
0 18
Treatment
  • selumetinib
  • vemurafenib
NCKAP5L (human) FGGsRTPstSDMAEE S1295-p
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) FGGsRTPstSDMGEE S1284-p
NCKAP5L (rat) FGGSRTPSTSDMGEE S1286
T1296-p
GGsRTPstSDMAEEG
0 3
NCKAP5L (human) GGsRTPstSDMAEEG T1296-p
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) GGsRTPstSDMGEEG T1285-p
NCKAP5L (rat) GGSRTPSTSDMGEEG T1287
S1307
AEEGRVASGGPPGLE
0 1
NCKAP5L (human) AEEGRVASGGPPGLE S1307
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) GEEGRVASGGAPGLE S1296
NCKAP5L (rat) GEEGRVAsGGAPGLE S1298-p
S1316
GPPGLETSESLSDSL
0 1
NCKAP5L (human) GPPGLETSESLSDSL S1316
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) GAPGLETSESLSDSL S1305
NCKAP5L (rat) GAPGLETsESLsDSL S1307-p
S1320
LETSESLSDSLYDSL
0 1
NCKAP5L (human) LETSESLSDSLYDSL S1320
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) LETSESLSDSLYDSL S1309
NCKAP5L (rat) LETsESLsDSLYDsL S1311-p
S1326
LSDSLYDSLSSCGSQ
0 1
NCKAP5L (human) LSDSLYDSLSSCGSQ S1326
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) LSDSLYDSLSSCGSQ S1315
NCKAP5L (rat) LsDSLYDsLSSCGsQ S1317-p
S1332
DSLSSCGSQG_____
0 1
NCKAP5L (human) DSLSSCGSQG_____ S1332
NCKAP5L iso2 (human) gap -
NCKAP5L (mouse) DSLSSCGSQG_____ S1321
NCKAP5L (rat) DsLSSCGsQG_____ S1323-p